Increasing treatment options for cannabis dependence: a review of potential pharmacotherapies.
about
Pharmacotherapies for cannabis dependencePharmacotherapy for cannabis dependence: how close are we?Marijuana dependence and its treatment"Spice" and "K2" herbal highs: a case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humans.Time-course of the DSM-5 cannabis withdrawal symptoms in poly-substance abusersDelta9-tetrahydrocannabivarin testing may not have the sensitivity to detect marijuana use among individuals ingesting dronabinol.Cognitive function as an emerging treatment target for marijuana addictionBAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP.Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network.Cannabis use disorder: epidemiology and management.Comparison of cannabis and tobacco withdrawal: severity and contribution to relapse.Pharmacological treatment of cannabis dependence.Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapseA within-subject comparison of withdrawal symptoms during abstinence from cannabis, tobacco, and both substancesCrude estimates of cannabis-attributable mortality and morbidity in Canada-implications for public health focused intervention priorities.Future of God in recovery from drug addiction.Tolerability and effects of oral Delta9-tetrahydrocannabinol in older adolescents with marijuana use disorders.[Pharmacological and psychosocial interventions for cannabis use disorders].Pharmacological enhancement of endocannabinoid signaling reduces the cholinergic toxicity of diisopropylfluorophosphate.Pericyazine in the treatment of cannabis dependence in general practice: a naturalistic pilot trialSynthetic Pot: Not Your Grandfather's Marijuana.The burden of disease attributable to cannabis use in Canada in 2012.Which medications are suitable for agonist drug maintenance?Baclofen in the management of cannabis dependence syndrome.Treatment of cannabis dependence using escitalopram in combination with cognitive-behavior therapy: a double-blind placebo-controlled study.Circuit breakers for addiction.
P2860
Q24187250-6ACFD00A-6A68-40B7-A048-9A22C722C4BEQ24648976-8838EA79-E6E8-4D48-BAD1-1290A4A6754FQ24655193-F3BD3F91-21D4-40D8-9F51-BBD38187CE3AQ30455650-F37564E8-800D-4B58-8DD9-73A8336E4E7AQ33587307-A4FC6FC8-9121-4B25-B419-299BD17EA07CQ33624781-0C20B0A4-6E69-458A-941F-2C45075AD1CEQ34018386-39EEC08E-3D57-489A-927A-FBDD6A083CAEQ34277168-8E440B6A-9167-4884-BF92-800F6D99854CQ34613783-BC8AC78D-385C-4339-913A-CAAB9FEFF234Q34975761-762FECB9-1200-4C8A-B60F-8C44787C81ACQ35133776-A5754FD2-6B55-4730-87D9-831BE5DB8F08Q35210350-E1E815AE-301A-4B91-93B1-C2F140CD2869Q36024183-0AFAED85-66A9-4264-973A-AE4A346360B3Q36406999-B59493B6-9DFC-4566-8BF1-8D26E1B5B47CQ36571381-38D78370-4A8D-4BB0-AC47-368D6B6710DBQ36935431-C3C7E712-B108-4DEA-82F6-6FA548E066C6Q36936109-1881CBE0-D964-4520-9357-1BD9D83D01DDQ36948826-A5004BF2-814A-4C50-922D-E2067649125EQ37137506-FDB92E47-54D3-45CA-B098-0CD51066FF5BQ37457289-0783BF94-4DB8-4B6D-AE9A-BC807D43BDE9Q39120303-17FEE9E0-4014-409B-9993-F378C6E305F2Q40283819-36AC6247-EF3B-4838-AADB-1182C2DDF496Q40390581-4D6195DF-128D-407F-9D28-DA129619EF39Q41879795-279D1190-477F-48FA-8789-B7D7A1454FA3Q47817946-3B209766-8839-4B61-ACCD-E667D7590289Q52291157-BEDB9BA3-41CC-431F-9773-B717211CD3AD
P2860
Increasing treatment options for cannabis dependence: a review of potential pharmacotherapies.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Increasing treatment options f ...... f potential pharmacotherapies.
@ast
Increasing treatment options f ...... f potential pharmacotherapies.
@en
type
label
Increasing treatment options f ...... f potential pharmacotherapies.
@ast
Increasing treatment options f ...... f potential pharmacotherapies.
@en
prefLabel
Increasing treatment options f ...... f potential pharmacotherapies.
@ast
Increasing treatment options f ...... f potential pharmacotherapies.
@en
P1476
Increasing treatment options f ...... f potential pharmacotherapies.
@en
P2093
Carl L Hart
P304
P356
10.1016/J.DRUGALCDEP.2005.03.027
P577
2005-11-01T00:00:00Z